Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Latest News about LILLY DRN
Recent news which mentions LILLY DRN
Healthy Returns: Eli Lilly’s cholesterol pill impresses in mid-stage trial
November 19, 2024
Tags
Health care industry
Novartis AG
Healthy Returns
From
CNBC.com News
Cramer's Lightning Round: Eli Lilly is a buy
November 18, 2024
Tags
U/S/ Markets
Business News
Integrated Electrical Services Inc
From
CNBC.com News
Cramer says an RFK Jr.-run HHS ultimately won't tank junk food and drug industries
November 15, 2024
Tags
Investing
Moderna Inc
Business News
From
CNBC.com News
Amgen stock falls as analysts mull over weight loss drug’s bone density data
November 12, 2024
Tags
Health care industry
Novo Nordisk A/S
Biotech and Pharmaceuticals
From
CNBC.com News
‘Two-stocks’ are better than one? Repacking ‘pair trades'
November 09, 2024
Tags
New York Times Co
Investment strategy
Finance
From
CNBC.com News
Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca
November 08, 2024
Tags
Social issues
AstraZeneca PLC
Health & Science
From
CNBC.com News
Jim Cramer says CEOs must properly explain the bad news in every quarter
October 30, 2024
Tags
Markets
NVIDIA Corp
Investment strategy
From
CNBC.com News
Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says
October 30, 2024
Tags
Business
Pharmaceuticals
Breaking news
From
CNBC.com News
Eli Lilly's Zepbound and Mounjaro are no longer in shortage. Here's where their sales still fell short
October 30, 2024
Tags
Biotechnology
US: News
Companies
From
CNBC.com News
Jim Cramer's top 10 things to watch in the stock market Wednesday
October 30, 2024
Tags
Snap Inc
CNBC Investing Club: Newsletter
CNBC Investing Club: Analysis
From
CNBC.com News
Eli Lilly stock tumbles 10% after missing estimates and slashing profit guidance
October 30, 2024
Tags
Pharmaceuticals
Business
LILLY DRN
From
CNBC.com News
Wednesday's big stock stories: What’s likely to move the market in the next trading session
October 29, 2024
Tags
Microsoft Corp
KB Home
Trump Media & Technology Group Corp
From
CNBC.com News
Cramer’s week ahead: Earnings from Alphabet, Meta, Apple, Microsoft and Amazon
October 25, 2024
Tags
Stock markets
stocks
DoorDash Inc
From
CNBC.com News
Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
October 24, 2024
Tags
Business
Weight management
Pharmaceuticals
From
CNBC.com News
Cramer's Lightning Round: 'Wait for a pullback' with Eli Lilly
October 23, 2024
Tags
Markets
Dutch Bros Inc
Stock Picks
From
CNBC.com News
Healthy Returns: Weight loss, diabetes drugs may reduce alcohol and opioid use
October 23, 2024
Tags
LILLY DRN
Healthy Returns
Health care industry
From
CNBC.com News
Novo Nordisk asks FDA to ban compounding pharmacies from making Ozempic, Wegovy copies
October 23, 2024
Tags
Business
Pharmaceuticals
LILLY DRN
From
CNBC.com News
KKM Financial's Essential 40 stock fund is now an ETF
October 21, 2024
Tags
Markets
Investing
Amazon/com Inc
From
CNBC.com News
Healthy Returns: Covering weight loss drugs could cost Medicare $35 billion through 2034
October 15, 2024
Tags
Health care industry
Healthy Returns
LILLY DRN
From
CNBC.com News
Eli Lilly to trial use of weight loss drugs to combat unemployment in UK
October 15, 2024
Tags
Pharmaceuticals
Business
LILLY DRN
From
CNBC.com News
Wegovy and Zepbound rival targeting 'next generation' of obesity drugs, Zealand Pharma CEO says
October 11, 2024
Tags
Biotechnology
Europe: Top News And Analysis
Biotech and Pharmaceuticals
From
CNBC.com News
Friday's big stock stories: What’s likely to move the market in the next trading session
October 03, 2024
Tags
Valero Energy Corp
Tencent Holdings Ltd
Diamondback Energy Inc
From
CNBC.com News
5 things to know before the stock market opens Thursday
October 03, 2024
Tags
Stellantis NV
Markets
Politics
From
CNBC.com News
Eli Lilly to build $4.5 billion research and manufacturing center to propel drug pipeline
October 02, 2024
Tags
LILLY DRN
Science
Health care industry
From
CNBC.com News
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.